Introduction
Neurogenesis persists in two germinal regions of the adult mammalian brain: the subventricular zone (SVZ) of the lateral ventricle (LV; Alvarez-Buylla and Garcia-Verdugo, 2002 ) and the subgranular zone (SGZ) in the hippocampal dentate gyrus (Okano, 2002; Kempermann et al., 2004; Okano and Sawamoto, 2008) . These neurogenic niches provide microenvironments that regulate the proliferation and differentiation of neural stem cells (Spradling et al., 2001; Song et al., 2002; Fuchs et al., 2004; Shen et al., 2004 Shen et al., , 2008 Tavazoie et al., 2008) . In the SVZ niche, stem cell astrocytes (Type B cells) divide slowly to generate neuroblasts (Type A cells) via rapidly dividing transit-amplifying cell intermediates (Type C cells) (Doetsch et al., 1999) . Cell proliferation and neurogenesis within the niche are regulated by spatially and temporally coordinated cues, including cell-cell communication involving the extracellular matrix and diffusible factors such as FGF-2 and EGF (Riquelme et al., 2008) .
Purine nucleotides, particularly ATP and ADP, are a class of metabolites that act as extracellular signals via P2/ATP receptors: the ionotropic P2X and metabotropic G-protein-coupled P2Y classes of receptors (Burnstock, 1996; Ralevic and Burnstock, 1998) . In the CNS, purinergic signaling is critical for a variety of cellular functions including proliferation, migration, and intercellular communication (Franke et al., 2006; Zimmermann, 2006; Maria et al., 2008) . Purinergic signaling has also been implicated in developmental and adult neurogenesis. In the fetal brain, for instance, ATP promotes the proliferation of radial glia, which are neural stem cells in the fetal brain, through the P2Y1 receptor. In contrast, P2Y1 antagonists such as suramin and MRS2179 inhibit the proliferation of radial glia (Weissman et al., 2004) .
ATP-mediated purinergic signaling through the P2Y receptor also promotes the expansion of neurospheres derived from fetal or adult brains. P2Y1 and P2Y2 receptors regulate the expansion of adult SVZ-derived neurospheres by mediating calcium release from the endoplasmic reticulum to the cytoplasm. Thus, agonists for these receptors induce calcium release, which in turn func-tions as a mitogen in adult mouse SVZ-derived neurospheres (Mishra et al., 2006) . In addition, previous reports suggest the expression of P2Y1, P2Y2, and/or P2Y4 receptors in the lateral wall of the adult mouse LV (Mishra et al., 2006; Lin et al., 2007) . Therefore, ATP-mediated purinergic signaling has been speculated to play important roles in adult neurogenesis in the SVZ, especially in cell proliferation. However, the in vivo roles of ATPmediated purinergic signaling in the adult SVZ have yet to be determined. We investigated in this study the in vivo functions of ATP-mediated purinergic signaling in neurogenesis in the adult SVZ.
Materials and Methods
Animals. Adult male CD-1 mice (8 weeks old) and C57BL/6 mice (8 weeks old) were purchased from Japan SLC. P2Y1 knock-out mice (C57BL/6 background) have been previously described (Léon et al., 1999) . The animals were maintained on a 12 h light/dark cycle with unlimited access to food and water. All animal-related procedures were performed in accordance with the Keio University guidelines and regulations.
Infusion into the SVZ.
) dissolved in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 ) or vehicle alone was infused into the lateral ventricle (0.2 mm posterior, 0.9 mm lateral to bregma and at a depth of 2.1 mm from the scalp) at 0.5 l/h for the stated number of days using the Brain Infusion Kit 3 (Alzet) and an osmotic pump (Alzet).
Bromodeoxyuridine labeling. For short-term labeling, mice received intraperitoneal injections of bromodeoxyuridine (BrdU; 50 mg/kg in PBS) every 200 min for 10 h after the intraventricular infusion and were killed 200 min after the last injection. For long-term labeling, 1 mg/ml BrdU was administered to mice via the drinking water for 2 weeks (Doetsch et al., 1999; Johansson et al., 1999; Sakaguchi et al., 2006; Imaizumi et al., 2011) . Following the BrdU administration, normal water was then provided for 1 week as "7 d washout time." Mice were infused with ATP, ATP antagonist, or PBS for 7 d after the switch from BrdU to normal water and then killed immediately. The brains were then processed for immunohistochemistry.
Reverse transcriptase PCR analysis. Total RNA was isolated from the SVZ using TRIzol reagent (Invitrogen). The RNA was processed with the RNeasy Mini Kit (Qiagen), and then treated with DNase I. cDNA was synthesized with Superscript 3 (Invitrogen) using oligo-d(T) 12-18 primers. RNA isolation and cDNA production were previously described (Okada et al., 2004) . P2Y1, P2Y2 and P2Y4 primer sets were previously described (Mishra et al., 2006) (P2Y1F: 5Ј-CCTG  CGAAGTTATTTCATCTA-3Ј;P2Y1R:5Ј-GTTG  AGACTTGCTAGACCTCT-3Ј;P2Y2F:5Ј-TCTG  CTTCCTGCCTTTCCAC-3Ј; P2Y2R: 5Ј-TCCG  TCTTGAGTCGTCACTG-3Ј; P2Y4F: 5Ј-AGCC  CAAGTTCTGGAGATGGTG-3Ј; P2Y4R: 5Ј-GGTGGTTCCATTGGCATTGG-3Ј) . PCR was performed in a volume of 25 l using the KOD Plus kit (Toyobo) according to the manufacturer's instructions. The PCR included 28 cycles with an annealing temperature of 55°C.
Real-time PCR analysis. Total RNA purified from the SVZ and cortex was reversetranscribed to cDNA (100 -200 ng). The amounts of the PCR products corresponding to the P2Y1, P2Y2, and P2Y4 receptors were normalized to ␤-actin. The P2Y1, P2Y2, or P2Y4 primer sets used were as follows: P2Y1qF: 5Ј-AGGCCACGCGCTCT-CCAAAAGA-3Ј; P2Y1qR: 5Ј-ACCTTGCAACCCGGGACCTTCA-3Ј; P2Y2qF: 5Ј-GCGGCTGCTCAAACCGGCTTAT-3Ј; P2Y2qR: 5Ј-AAGG-CAGGAAGCAGAGGGCGAA-3Ј; P2Y4qF: 5Ј-ACTCATGGCCCGGC-GACTGTAT-3Ј; P2Y4qR: 5Ј-GCGGGTGATGTGGAAAGGCACAA-3Ј. The ␤-actin primer set was previously described (Okada et al., 2004) . Real-time PCR was performed in a final volume of 25 l using SYBR Premix Ex Taq (Takara) according to the manufacturer's instructions with a Mx3000P cycler (Stratagene). The PCR included 45 cycles with an annealing temperature of 60°C.
Immunoblotting. SVZs were dissected and homogenized in MAPKlysis buffer (containing, in mM: 10 Tris-HCl, pH 7.6, 50 NaCl, 30 Na 3 PO 4 , 50 NaF, 20 ␤-glycerophosphoric acid, 1% Triton X-100). Protein concentrations were determined using the BCA assay kit (Thermo Fisher Scientific) and 20 or 30 g of protein were separated by SDS-PAGE and then electroblotted onto polyvinylidene difluoride mem- branes. The membranes were incubated with rabbit polyclonal antibodies directed against the P2Y1 receptor (1:1000; MBL International) or mouse polyclonal antibodies directed against ␣-tubulin (1: 5000; Sigma). Signals were detected with the luminescence assay kit (GE Healthcare, Thermo Fisher Scientific).
Immunohistochemistry. Brains were perfusion-fixed with 4% paraformaldehyde, followed by an overnight postfixation in the same fixative at 4°C. Sections (50 m) were prepared on the next day with a Vibratome (VT1000S; Leica). After three rinses in PBS, sections were incubated either in ethanol/acetone (50:50) for 30 min at Ϫ20°C [for GFAP (glial fibrillary acidic protein)] or in 2 N HCl for 30 min (for BrdU). The sections were then incubated for 1 h in the TNB (Tris-NaCl blocking) solution (Vector Laboratories), then overnight with one of the primary antibodies, followed by a 1 h incubation at room temperature with HRPconjugated secondary antibody (1:250) or Alexa Fluor-conjugated secondary antibody (1:250; Invitrogen). HRP-conjugated antibodies were visualized using TSA (PerkinElmer Life and Analytical Sciences). The following primary antibodies were used in this study: mouse monoclonal Quantitative analysis of immunohistochemistry. Using the vibratome sectioning system, a complete set of coronal sections of the forebrain was first prepared. For each protein, a set of two random-systematically selected coronal sections, one from the anterior half (between 1.18 mm anterior and 0.58 mm anterior to bregma) and the other from the posterior half (between 0.58 mm anterior and 0.02 mm posterior to bregma) of the anterior horn, was subjected to immunohistochemical analysis (Adachi et al., 2007) . Imaging was performed using a PASCAL Laser Scanning Confocal Microscope or LSM700 Laser Scanning Confocal Microscope (both Zeiss). Quantitative analysis was performed with two randomly selected sections from at least two different mice. The total numbers of detectable cells for each marker were counted in the SVZ on the side contralateral to the infusion.
Statistical analysis. All quantified data are expressed as the mean Ϯ SEM. Differences between two mean values were evaluated with the unpaired Student's t test and considered statistically significant when the p value was Ͻ0.05.
Results

ATP promotes proliferation of rapidly dividing cells and Type C cells
ATP has been shown to promote not only the proliferation of radial glial cells in the fetal brain, but also the expansion of neurospheres derived from both adult SVZ and fetal cortex (Weissman et al., 2004; Mishra et al., 2006; Lin et al., 2007) . Therefore, it has been suggested that ATP can act as a trophic factor, which is defined as an extracellular substance that stimulates cell division and/or proliferation, in adult neurogenesis. However, whether ATP has in vivo trophic functions in the SVZ and, if so, which cell type(s) is/are affected by ATP has remained unclear.
Two major types of proliferating cells are found in the SVZ: rapidly dividing transit-amplifying cells (Type C cells) and slowly dividing neural stem cells (NSCs; Type B cells). We first investigated whether ATP has trophic effects on these two cell types. When applied, the thymidine analog BrdU becomes incorporated into the replicating DNA during the S phase of the cell cycle. Thus, mitotic cells can be identified with anti-BrdU antibodies. Short administration of BrdU mainly labels rapidly dividing cells, which include rapidly dividing Type C cells, whereas long BrdU administration together with 7 d washout time mainly labels slowly dividing cells which include slowly dividing Type B cells (Doetsch et al., 1999; Johansson et al., 1999; Sakaguchi et al., 2006; Imaizumi et al., 2011) .
The LVs of 8-week-old mice were continually infused with ATP, an ATP antagonist or PBS for 3 d. Mice were then injected with BrdU every 200 min for 10 h before they were killed ("short-term" BrdU labeling method; Fig. 1 A) . As a first step to examine the role of P2/ATP receptor in neurogenesis, we also used a broad-spectrum P2 receptor antagonist, suramin. Doses of either 2 g ⅐ kg Ϫ1 ⅐ h Ϫ1 ATP or 24 g ⅐ kg Ϫ1 ⅐ h Ϫ1 suramin were used for these experiments. PBS was infused into control mice. Brain sections of these mice including the SVZ were then immunostained with anti-BrdU antibody, and the number of BrdU ϩ cells in the SVZ was determined. To exclude the possible inflammatory effects of infusion, the side of the LV contralateral to the infusion was examined. BrdU ϩ cells were significantly increased in the ATP-infused group compared with the PBS-infused control group (Fig. 1 A-C ; p Ͻ 0.05; n ϭ 6 each). In contrast, the number of BrdU ϩ cells significantly decreased in the suramin-infused group compared with the PBS-infused control ( Fig. 1 B, C ; p Ͻ 0.05; n ϭ 6 per group). BrdU labels dividing cells and dead cells (Cooper-Kuhn and Kuhn, 2002) . We therefore also performed immunohistochemistry to analyze the sections for activated Caspase 3. While we detected Ͼ170 BrdUpositive cells, we only found less than one activated Caspase 3-positive cell per section in ATP-, suramin-, and PBS-infused mice (ATP-infusion group 0.75 Ϯ 0.89, PBS-infused group 0.25 Ϯ 0.46, suramin-infused group 0.75 Ϯ 0.89; n ϭ 4 per group). Collectively, very little ongoing cell death was detected in the adult SVZ and BrdU-/activated Caspase 3-double-positive cells were very rare, suggesting that actually proliferating cells, but not dead or dying cells, incorporated BrdU.
To identify the cell type(s) that displayed increased proliferation upon ATP infusion, sections of ATP-treated mice were pro- cessed for double-label immunohistochemistry with an antibody against BrdU in combination with one of the following cell typespecific markers: microglial cell marker Iba1 (Imai et al., 1996) , Type A cell marker doublecortin (Dcx; Doetsch et al., 1997) , Type B cell marker GFAP (Doetsch et al., 1997 (Doetsch et al., , 1999 , and Type C cell marker Mash1 (Parras et al., 2004; Sakaguchi et al., 2006; Adachi et al., 2007; Kim et al., 2007 Kim et al., , 2011 . Microglial cells become activated by purinergic signaling upon inflammation (Färber and Kettenmann, 2006; Inoue, 2008) . We found that 49.6% of BrdU-positive cells also expressed one of these cell type-specific markers. Among these double-positive cells, the largest fraction (38.3%) comprised Mash1-positive cells, whereas 36.8% were Dcx-positive Type A cells and 6.8% were GFAP-positive Type B or glial cells. Also, 18.2% of BrdUpositive cells were Iba1-positive microglial cells ( Fig. 2A-D) . These data indicate that the fraction of Type C cells within the total BrdU ϩ cell population was increased significantly by ATP infusion. Therefore, we next examined whether the number of Mash1-positive cells was increased by ATP infusion. 
Quantification of Mash1
ϩ cells in ATP-, suramin-, and PBSinfused mice revealed a significant increase in Mash1 ϩ cells in the ATP-infused group ( p Ͻ 0.05; n ϭ 6 per group), and a nonsignificant decrease in the suramin-infused group ( p ϭ 0.07), relative to the PBS-infused control group (Fig. 2 E, F ) .
ATP does not affect the proliferation of slowly dividing cells and Type B cells
Next, we examined whether ATP has similar trophic functions in slowly dividing cells. Since Type B cells divide slowly, a "long-term" BrdU labeling protocol was used for labeling of slowly dividing cells and Type B cells. To this end, mice were orally administered (in drinking water) BrdU for 14 d. Following the BrdU administration, normal water was then provided for 7 d as (Fig. 3A) . After this treatment, 2 g ⅐ kg Ϫ1 ⅐ h Ϫ1 ATP, 24 g ⅐ kg Ϫ1 ⅐ h Ϫ1 suramin, or PBS was continuously infused into the LV for 7 d. The effects of purinergic signaling on Type B cells were then analyzed. As above, the number of BrdU ϩ cells in the SVZ on the side contralateral to the infusion was counted. The number of BrdU ϩ cells did not change in the ATP-infused or suramin-infused group compared with the PBSinfused control group (Fig. 3B,C ; n ϭ 6 per group).
To characterize the BrdU-positive cells, we performed immunohistochemistry to analyze brain sections in the same manner as above. We found that 50.1% of BrdU-positive cells expressed one of these markers. In these double-positive cells, the largest fraction was GFAP positive; 38.1% were GFAPpositive Type B or glial cells, 22.1% were Dcx-positive Type A cells, 17.7% were Mash1-positive Type C cells and 22.1% of BrdU-positive cells were Iba1-positive microglial cells (Fig.  4 A-D) .
Then, we examined whether or not GFAP-positive cells were increased by ATP infusion. We, therefore, counted the number of BrdU/GFAP double-positive Type B and glial cells in ATPinfused mice by using histochemical analysis. The number of double-positive cells in the ATP-infused or suramin-infused groups did not significantly differ from the number of these cells in the PBS-infused control group (Fig. 4 E, F ; n ϭ 6 per group).
P2Y1 receptor is a mediator of ATP-induced proliferation of rapidly dividing cells and Type C cells
To gain insight into the involvement of purinergic signaling receptors in the ATP-mediated promotion of Type C cell proliferation, we next assessed their expression patterns in the adult mouse SVZ by semiquantitative PCR, immunoblot analysis, and immunohistochemistry.
As mentioned above, P2Y1, P2Y2 and P2Y4 receptor expression has been suggested in the SVZ (Mishra et al., 2006; Lin et al., 2007) , and P2Y1 and P2Y2 receptors were shown to be involved in the proliferation of adult SVZ-derived neurospheres (Mishra et al., 2006) . To determine which type(s) of P2Y receptors were crucial for ATP-mediated promotion of rapidly dividing cell proliferation, reverse transcriptase (RT)-PCR analysis was performed using RNA prepared from adult mouse SVZ. The results of the semiquantitative RT-PCR analysis showed that P2Y1 and P2Y4 receptors were more highly expressed in the adult mouse SVZ than P2Y2 receptors (Fig. 5A) . Additional cycles of amplification were needed to detect P2Y2 receptors.
To address the importance of these receptors in the adult SVZ, we compared the expression patterns of these receptors between the SVZ and cortex using real-time PCR. The results revealed that the relative expression levels in the SVZ compared with the cortex were higher for P2Y1 (ϳ7) than P2Y4 (ϳ4) (Fig. 5B) . This indicates the importance of P2Y1 for adult neurogenesis in the neurogenic niche. Moreover, previous data suggested that the P2Y1 receptor is the main receptor necessary for ATP-mediated radial glia proliferation and expansion of neurospheres derived from the fetal brain or adult SVZ. These data suggest that P2Y1 is the major purinergic receptor responsible for the ATP-induced promotion of rapidly dividing cell proliferation in the SVZ. Therefore we focused on the P2Y1 receptor.
Immunoblot analysis was performed using lysates prepared from the adult mouse SVZ to investigate whether P2Y1 protein is expressed in the SVZ. The mouse embryonal carcinoma cell line P19, which is known to express the P2Y1 receptor (Resende et al., 2007) , was used as a positive control. Interestingly, P2Y1 expression was observed in the SVZ (Fig. 5C ). To determine which cell type expressed the P2Y1 receptor in the SVZ, we performed immunohistochemistry using antibodies against Dcx, Mash1, and GFAP. The P2Y1 receptor was expressed in 73.2% of Dcx ϩ Type A and 31.1% of Mash1 ϩ Type C cells, but not in BrdU/GFAP double-positive Type B cells (Fig. 5D-F ) .
To confirm that the P2Y1 receptor is indeed involved in the ATPmediated promotion of rapidly dividing cell proliferation, 6 g ⅐ kg Ϫ1 ⅐ h Ϫ1 of the novel P2Y1-specific antagonist MRS2179 was continuously infused into the LVs of 8-week-old mice for 3 d, followed by short-term BrdU labeling (Fig. 6A ). The infused brains were then subjected to immunohistochemical analysis. The number of BrdU ϩ cells was significantly lower in the MRS2179-infused group than in the PBS-infused control group (Fig. 6B,C ; p Ͻ 0.05; n ϭ 6 per group). The number of Mash1-positive cells was also significantly lower in the MRS2179-infused group than in the PBS-infused control group (Fig. 6D,E ; p Ͻ 0.05; n ϭ 6 per group). We also performed immunohistochemistry to analyze the sections for activated Caspase3 to determine whether MRS2179 infusion affected cell death. The amount of activated Caspase3 was not significantly different between the MRS2179-infused group and the PBS-infused group (PBS-infused group, 0.25 Ϯ 0.46; MRS2179-infused group, 0.25 Ϯ 0.27; n ϭ 4 per group). To further investigate the functions of the P2Y1 receptor, we analyzed the proliferation of rapidly dividing cells in P2Y1 knockout mice. It is important to note that, whereas the other experiments investigated the effects of purinergic signaling in CD-1mice, the P2Y1 knock-out mice were on a C57BL/6 background. Since adult neurogenesis is differentially influenced by the genetic background of the mice (Kempermann et al., 1997; Schauwecker, 2006) , we examined whether the different genetic backgrounds had an impact on our study. We performed the experiments using the P2Y1-specific antagonist and C57BL/6 mice, and confirmed that the number of BrdU-positive cells was significantly reduced in the MRS2179 infusion group (240 Ϯ 17 cells, *p Ͻ 0.05 vs PBS-infused brain, n ϭ 6) compared with the PBS-infused control group (322 Ϯ 37 cells, n ϭ 6). This was the same result that we observed using CD-1 mice. Therefore, we used P2Y1-deficient mice on a C57BL/6 background to further investigate P2Y1 receptor functions. Adult neurogenesis was examined in P2Y1-deficient mice with short-term BrdU labeling (Fig. 7A) . The number of BrdU-and Mash1-positive cells were both significantly lower in P2Y1-deficient mice than in wild-type mice ( Fig.  7B-E ; p Ͻ 0.05; n ϭ 6 per group). The number of activated Caspase3-positive cells was similar in P2Y1-deficient mice and wildtype mice (WT, 1.5 Ϯ 0.38; P2Y1-deficient, 1.13 Ϯ 1.48; n ϭ 4 per group). To determine whether P2Y1 is required for ATP mitogenic stimulation, ATP was continuously infused into the LVs of 8-week-old wild and P2Y1-deficient mice for 3 d. We then performed short-term BrdU labeling (Fig. 8A ) and subjected the in- fused brains to immunohistochemical analysis. The ATP-infusion did not increase the number of BrdU ϩ cells in P2Y1-deficient mice ( Fig. 8B,C ; n ϭ 6 per group), suggesting that P2Y1 was required for ATP mitogenic stimulation. On the other hand, the number of BrdU ϩ cells was significantly lower in the SVZ of P2Y1-deficient mice brains than in the PBS-infused control group (Fig. 8B,C ; n ϭ 6 per group). However, the mechanism responsible for this decrease still remains unknown.
Together, these results strongly suggest that ATP-induced promotion of the proliferation of rapidly dividing cells and Type C cells is mainly mediated by the P2Y1 receptor.
Discussion
Persistent neurogenesis has been shown to occur in two restricted areas of the adult mammalian brain: the SVZ (Alvarez-Buylla and Garcia-Verdugo, 2002 ) and the SGZ of the hippocampus (Okano, 2002; Kempermann et al., 2004; Okano et al., 2008) . Although the molecular mechanisms of adult neurogenesis have been extensively investigated, the in vivo roles of purinergic signaling in adult neurogenesis have not yet been elucidated.
Purinergic signaling, mainly mediated by ATP, has been speculated to regulate adult neurogenesis because it is important for the proliferation of various cell types during development (Zimmerman, 2006) , including cortical radial glial cells (Weissman et al., 2004) , retinal progenitors (Sugioka et al., 1996; Pearson et al., 2002; Nunes et al., 2007) , and olfactory epithelium progenitors (Hassenklöver et al., 2009 ) in the CNS. Purinergic signaling receptors and nucleotide breakdown enzymes such as ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase2) and tissue-nonspecific alkaline phosphatase are also present in the SVZ (Braun et al., 2003; Langer et al., 2007) . Moreover, adenosine kinase, which controls adenosine homeostasis and ATP synthesis, is highly expressed in the SVZ. The existence of these enzymes in the SVZ strongly indicates the importance of purinergic signaling in the region. In addition, although ATP is not suitable for distal extracellular signaling because it is unstable and subject to rapid degradation, it is suitable for cell-cell communication within microenvironments such as the SVZ niche (Yegutkin, 2008) .
These previous reports support the hypothesis that ATP plays important roles in adult neurogenesis in the SVZ. In this study, we attempted to elucidate whether ATP-mediated purinergic signaling functions to promote the proliferation of cells in the SVZ. Infusion of ATP into the LVs of adult mice increased the number of BrdUpositive and Mash1-positive cells, whereas suramin infusion decreased these numbers. As mentioned above, BrdU labels both dying and newborn cells (Cooper-Kuhn and Kuhn, 2002) . The increase in BrdU-positive cells, therefore, could reflect increased apoptosis. However, immunohistochemical analysis revealed that Ͻ0.4% of BrdU-positive cells were also positive for activated Caspase3. Thus, BrdU immunoreactivity was rarely identified in apoptotic cells, and minimal cell death was observed in the SVZ. These results suggest that the majority of the BrdU-positive cells were newborn, rather than dying, cells. Furthermore, our data showed no significant difference in the number of apoptotic cells when either purinergic signaling antagonist-infused or P2Y1-deficient mice were compared with WT mice. Thus, it is unlikely that purinergic signaling plays a major role in regulating cell death/survival in the adult SVZ. It is also true that BrdU-positive cells merely represent that the cells have been entered or had been entered S phase. However, the increased number of Mash1-positive cells was observed in ATP-infused mice as well as the number of BrdU-positive cells. These data suggested that most BrdU-positive cells had been survived. Therefore, our results suggest that purinergic signaling promotes the proliferation of rapidly dividing cells.
We next investigated the involvement of purinergic signaling receptors in the ATP-mediated promotion of cell proliferation. Expression of the purinergic signaling receptors P2Y1, P2Y2, and P2Y4 and their contribution to the proliferation of neuronal precursor cells in the SVZ have been previously suggested (Mishra et al., 2006; Lin et al., 2007) . However, the cell types in the SVZ that express these receptors have not been elucidated. Our data revealed that the P2Y1 receptor is expressed in 73.2% of Type A and 31.1% of Type C cells.
To investigate the role of the P2Y1 receptor, in the ATPmediated promotion of the proliferation of rapidly dividing cells, the P2Y1 receptor-specific antagonist MRS2179 was infused into the LVs of adult mice, and a decrease was observed in the number of BrdU ϩ cells (after a short-term labeling protocol). The number of Mash1-positive cells was also decreased in the MRS2179-infused mice. Then, we further analyzed it in P2Y1 deficient mice.
P2Y1 knock-out mice are viable, with no apparent abnormalities affecting their development, survival, or reproduction (Léon et al., 1999) . Additionally, thorough examinations have revealed abnormal platelet aggregation and impaired long-term depression in the prefrontal cortex in those animals (Léon et al., 1999; Guzman et al., 2010) . These reports indicate the possibility of the presence of other abnormalities in the P2Y1 knock-out mice. In this study, we revealed that rapidly dividing cells and Type C cells were decreased in P2Y1 knock-out mice. Moreover, proliferation of rapidly dividing cells was reduced in ATP-infused P2Y1 knock-out mice compared with the PBS-infused ctrl P2Y1 knock-out mice group. These data also indicate the importance of purinergic signaling via P2Y1 receptors. Further studies using P2Y1 knock-out mice are necessary to determine the signal cascade downstream of P2Y1.
What is the source of ATP? The SVZ contains many candidate ATP sources including blood vessels, proliferating cells, neurons, astroglial cells, and microglial cells (Weissman et al., 2004; Fields and Burnstock, 2006) . Previous reports demonstrate that many cell types release ATP, including proliferating cells, neurons, and astrocytes (Burnstock, 2007) . Also, in the fetal cortex, radial glial cells have been reported to secrete ATP through connexin hemichannels during S phase (Weissman et al., 2004) . Furthermore, endothelial cells in the adult mouse SVZ express connexin (Cx), and it is known that neocortical astrocytes release ATP via Cx43 (Haas et al., 2006) . Thus, many cell types might release ATP depending on the cues or demands of the SVZ niche.
This study demonstrated that ATP is an important small molecule for the proliferation of rapidly dividing cells and Type C cells in the adult mouse SVZ. Thus, purinergic signaling in the SVZ niche is important for the maintenance of adult neurogenesis in this niche. The physiological functions of purinergic signaling in the SVZ, however, still remain largely unknown. Better understanding of the diverse functions and complicated mechanisms of purinergic signaling in the SVZ will provide more detailed insights into the molecular mechanisms of adult neurogenesis and the homeostasis of the nervous system.
